Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03756350 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Safety and Efficacy of a 1060nm Diode Laser (Abdomen)
A NA study of Fat Atrophy, sponsored by Venus Concept.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT03756350 is a NA study of Fat Atrophy that has completed, run by Venus Concept. The registered enrollment target is 30 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03756350, a NA study of Fat Atrophy, has completed, sponsored by Venus Concept.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is evaluating a 1060nm diode laser for non-invasive fat reduction of the abdomen. The study will enrolled up to 50 subjects requesting non-invasive lipolysis of the abdomen. Each subject will receive a single study treatment. Subjects will be followed at six and twelve weeks post treatment. Twelve week outcomes will be compared to baseline.
Conditions Studied
Interventions
- DEVICE 1060nm diode laser
Study Locations (2)
California
- Laser and Skin Surgery Center of Northern California - Sacramento
Texas
- Southwestern Medical Center Department of Plastic Surgery - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-11-14 |
| Est. Completion | 2019-07-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03756350
The ClinicalTrials.gov registry entry for NCT03756350 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fat Atrophy appearing as the primary indexed condition, and to 1 intervention - of which 1060nm diode laser is the first listed.
NCT03756350 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Texas.
Frequently Asked Questions
What is clinical trial NCT03756350 about?
NCT03756350 is a clinical study titled "Clinical Evaluation of the Safety and Efficacy of a 1060nm Diode Laser (Abdomen)". This study is evaluating a 1060nm diode laser for non-invasive fat reduction of the abdomen. The study will enrolled up to 50 subjects requesting non-invasive lipolysis of the abdomen. Each subject will receive a single study treatment. Subjects will be followed at six and twelve weeks post treatmen...
What is the current status of trial NCT03756350?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-11-14. Estimated completion is 2019-07-02.
What conditions does trial NCT03756350 study?
This clinical trial studies the following conditions: Fat Atrophy.
What interventions are being tested in trial NCT03756350?
The interventions under investigation include: 1060nm diode laser (DEVICE).
Who is sponsoring clinical trial NCT03756350?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03756350 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.